Inspire Medical Systems, Inc. 參加了於 6 月 14 日至 17 日在馬里蘭州巴爾的摩舉行的 SLEEP 2026——即「專業睡眠學會聯合會」（APSS）第 40 屆年會。SLEEP 是睡眠醫學與研究領域的首要全球論壇，由美國睡眠醫學學會（AASM）與睡眠研究 […] 共同主辦。
Tag: INSPIRE MEDICAL SYSTEMS
Inspire Expands Leadership Team with Two Vice President, Senior Medical Director Appointments
Inspire Medical Systems, Inc. announced that two leading physicians in sleep medicine and sleep surgery, Paul T. Hoff, M.D., M.S., an otolaryngologist, and Ruchir P. Patel, M.D., F.A.C.P., a sleep medicine specialist, will join Inspire as Vice President and senior Medical Director, effective 四月 21 and 六月 2, respectively. “Dr. […]
舌下神經刺激：從概念到臨床實踐
雖然持續性正壓呼吸療法（CPAP）仍是阻塞性睡眠呼吸中止症（OSA）的黃金標準治療方式，但已有充分證據顯示，許多患者在長期遵從治療及耐受性方面面臨困難。¹ 文獻指出，CPAP 的未遵從率仍高達 34%，且過去二十年來幾乎未見改善。² 由於 […]
Inspire Announces Countrywide Reimbursement in France
Inspire Medical Systems, Inc. announced today the publication of the reimbursement of Inspire therapy in France. “We are thrilled to offer our clinically proven treatment option for moderate to severe OSA to patients and physicians in France,” said Tim Herbert, Chairman and Chief Executive Officer of Inspire. “Inspire therapy is […]
Inspire 2024 Revenue Projected to Grow 24% – 26% Over 2023
Today, Inspire Medical Systems, Inc. announced certain preliminary, unaudited results for the fourth quarter and full year that ended 十二月 31, 2023, and provided its initial full-year 2024 guidance. Preliminary, Unaudited Fourth Quarter and Full Year 2023 Revenue and Recent Business Highlights Revenue for the fourth quarter of 2023 is […]
Inspire Medical Systems Sees 40% surge in Third Quarter Revenue
Inspire Medical Systems, Inc. has reported financial results for the quarter ended 九月 30, 2023. Recent Business Highlights Generated revenue of $153.3 million in the third quarter of 2023, a 40% increase over the same quarter last year Achieved gross margin of 84.1% in the third quarter of 2023 Reduced loss […]
FDA Approves lnspire for AHI Indication Expansion and Increased BMI Labeling
Inspire Medical Systems, Inc. announced that it has received approval from the Food and Drug Administration (FDA) on an expanded indication. The update includes an increase on the upper limit of the Apnea-Hypopnea Index (AHI) to 100 events per hour from 65 and raises the Body Mass Index (BMI) warning […]
Inspire Announces Expanded FDA Approval for Pediatric Patients with Down Syndrome
Inspire Medical Systems, Inc. announced today that it has received approval from the Food and Drug Administration (FDA) to offer Inspire therapy to pediatric patients with Down syndrome. “Since our first FDA approval in 2014, the research team at Mass Eye and Ear, led by Dr. Christopher Hartnick, have pioneered […]
Ognomy Sleep Telemedicine Platform Drives Growth and Innovation
By RTSleepWorld Staff Since the 四月 2022 press release announcing their investment by Inspire Medical Systems, Ognomy, the telemedicine platform, and app, has grown and continues to innovate towards its mission of democratizing access to expert sleep apnea care. Ognomy is an easy and effective way for patients to consult […]
Inspire Therapy Now Full-Body MRI Compatible
Inspire Medical Systems, Inc. announced that the United States Food and Drug Administration (FDA) has approved additional magnetic resonance imaging (MRI) scan conditions for use with Inspire therapy. This full-body MRI approval expands the Inspire use labeling that previously allowed only head, neck, and extremity MRI scans. Most importantly, this […]
